Department of Cardiology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200011, China.
Center for Molecular Medicine, Tarrant County College, TX, 76102, USA.
Redox Biol. 2021 Sep;45:102049. doi: 10.1016/j.redox.2021.102049. Epub 2021 Jun 18.
Mitochondrial dysfunction is a fundamental challenge in septic cardiomyopathy. Mitophagy and the mitochondrial unfolded protein response (UPR) are the predominant stress-responsive and protective mechanisms involved in repairing damaged mitochondria. Although mitochondrial homeostasis requires the coordinated actions of mitophagy and UPR, their molecular basis and interactive actions are poorly understood in sepsis-induced myocardial injury. Our investigations showed that lipopolysaccharide (LPS)-induced sepsis contributed to cardiac dysfunction and mitochondrial damage. Although both mitophagy and UPR were slightly activated by LPS in cardiomyocytes, their endogenous activation failed to prevent sepsis-mediated myocardial injury. However, administration of urolithin A, an inducer of mitophagy, obviously reduced sepsis-mediated cardiac depression by normalizing mitochondrial function. Interestingly, this beneficial action was undetectable in cardiomyocyte-specific FUNDC1 knockout (FUNDC1) mice. Notably, supplementation with a mitophagy inducer had no impact on UPR, whereas genetic ablation of FUNDC1 significantly upregulated the expression of genes related to UPR in LPS-treated hearts. In contrast, enhancement of endogenous UPR through oligomycin administration reduced sepsis-mediated mitochondrial injury and myocardial dysfunction; this cardioprotective effect was imperceptible in FUNDC1 mice. Lastly, once UPR was inhibited, mitophagy-mediated protection of mitochondria and cardiomyocytes was partly blunted. Taken together, it is plausible that endogenous UPR and mitophagy are slightly activated by myocardial stress and they work together to sustain mitochondrial performance and cardiac function. Endogenous UPR, a downstream signal of mitophagy, played a compensatory role in maintaining mitochondrial homeostasis in the case of mitophagy inhibition. Although UPR activation had no negative impact on mitophagy, UPR inhibition compromised the partial cardioprotective actions of mitophagy. This study shows how mitophagy modulates UPR to attenuate inflammation-related myocardial injury and suggests the potential application of mitophagy and UPR targeting in the treatment of myocardial stress.
线粒体功能障碍是脓毒症性心肌病的一个基本挑战。自噬和线粒体未折叠蛋白反应(UPR)是修复受损线粒体的主要应激反应和保护机制。尽管线粒体稳态需要自噬和 UPR 的协调作用,但它们在脓毒症引起的心肌损伤中的分子基础和相互作用仍知之甚少。我们的研究表明,脂多糖(LPS)诱导的脓毒症导致心脏功能障碍和线粒体损伤。尽管 LPS 在心肌细胞中略微激活了自噬和 UPR,但它们的内源性激活未能防止脓毒症介导的心肌损伤。然而,自噬诱导剂尿石素 A 的给药明显通过正常化线粒体功能减轻了脓毒症介导的心脏抑制。有趣的是,这种有益作用在心肌细胞特异性 FUNDC1 敲除(FUNDC1)小鼠中无法检测到。值得注意的是,补充自噬诱导剂对 UPR 没有影响,而 LPS 处理的心脏中 FUNDC1 的遗传缺失显著上调了与 UPR 相关的基因的表达。相反,通过寡霉素给药增强内源性 UPR 可减少脓毒症引起的线粒体损伤和心肌功能障碍;在 FUNDC1 小鼠中,这种心脏保护作用难以察觉。最后,一旦 UPR 被抑制,自噬介导的线粒体和心肌细胞保护作用就会部分减弱。综上所述,内源性 UPR 和自噬可能被心肌应激轻度激活,它们共同维持线粒体功能和心脏功能。作为自噬下游信号的内源性 UPR,在自噬抑制的情况下,在维持线粒体稳态方面发挥了代偿作用。虽然 UPR 的激活对自噬没有负面影响,但 UPR 的抑制损害了自噬的部分心脏保护作用。这项研究表明了自噬如何调节 UPR 以减轻炎症相关的心肌损伤,并提示了靶向自噬和 UPR 在治疗心肌应激方面的潜在应用。